PL1828239T3 - Produkcja FGF18 w organizmach prokariotycznych - Google Patents

Produkcja FGF18 w organizmach prokariotycznych

Info

Publication number
PL1828239T3
PL1828239T3 PL05853969T PL05853969T PL1828239T3 PL 1828239 T3 PL1828239 T3 PL 1828239T3 PL 05853969 T PL05853969 T PL 05853969T PL 05853969 T PL05853969 T PL 05853969T PL 1828239 T3 PL1828239 T3 PL 1828239T3
Authority
PL
Poland
Prior art keywords
fgf18
coli
production
expression
ompt
Prior art date
Application number
PL05853969T
Other languages
English (en)
Inventor
Brian J Reardon
Susan D Julien
Chung-Leung Chan
Hong Y Liu
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of PL1828239T3 publication Critical patent/PL1828239T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]
    • C07K14/501Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/50Fibroblast growth factor [FGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL05853969T 2004-12-10 2005-12-12 Produkcja FGF18 w organizmach prokariotycznych PL1828239T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63502304P 2004-12-10 2004-12-10
PCT/US2005/045166 WO2006063362A1 (en) 2004-12-10 2005-12-12 Fgf18 production in prokaryotic hosts
EP05853969A EP1828239B1 (en) 2004-12-10 2005-12-12 Fgf18 production in prokaryotic hosts

Publications (1)

Publication Number Publication Date
PL1828239T3 true PL1828239T3 (pl) 2012-01-31

Family

ID=36061577

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05853969T PL1828239T3 (pl) 2004-12-10 2005-12-12 Produkcja FGF18 w organizmach prokariotycznych

Country Status (12)

Country Link
US (1) US7858341B2 (pl)
EP (1) EP1828239B1 (pl)
AT (1) ATE521633T1 (pl)
AU (1) AU2005314438B2 (pl)
CA (1) CA2592261C (pl)
CY (1) CY1112394T1 (pl)
DK (1) DK1828239T3 (pl)
ES (1) ES2371219T3 (pl)
PL (1) PL1828239T3 (pl)
PT (1) PT1828239E (pl)
SI (1) SI1828239T1 (pl)
WO (1) WO2006063362A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602006018969D1 (de) 2005-10-04 2011-01-27 Bristol Myers Squibb Co Herstellung und reinigung von il-29
ZA200900426B (en) * 2006-08-25 2010-04-28 Ares Trading Sa Treatment of cartilage disorders with FGF-18
CA2658511C (en) * 2006-08-25 2019-02-19 Ares Trading S.A. Use of fgf-18 compound to treat cartilage disorders
CN102482321B (zh) 2009-06-22 2015-06-17 安姆根有限公司 使用化学控制的氧化还原态重折叠蛋白质
WO2010151688A2 (en) 2009-06-25 2010-12-29 Amgen Inc. Capture purification processes for proteins expressed in a non-mammalian system
WO2012038953A2 (en) 2010-09-21 2012-03-29 Hepacore Ltd. Fgf-18 truncated variants having increased receptor specificity and uses thereof
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
TW201307563A (zh) * 2011-05-19 2013-02-16 Shire Human Genetic Therapies 純化乙醯肝素-n-硫酸酯酶之方法
TWI527590B (zh) 2011-06-17 2016-04-01 艾瑞斯貿易公司 Fgf-18之凍乾調配物
US9580692B2 (en) * 2012-02-29 2017-02-28 Ge Healthcare Bioprocess R&D Ab Method for endotoxin removal
US10041050B2 (en) 2012-02-29 2018-08-07 Ge Healthcare Bioprocess R&D Ab Method for endotoxin removal
CN104736723B (zh) 2012-08-06 2017-10-31 默克专利有限公司 用于预测对fgf‑18化合物的响应性的遗传标记
BR112016018681B1 (pt) * 2014-02-20 2021-01-05 Merck Patent Gmbh sistema de distribuição de substâncias que compreende pelo menos um material polimérico formador de uma matriz e um fármaco anabólico, processo de produção do mesmo e artigo de manufatura
KR101608734B1 (ko) 2014-03-21 2016-04-04 씨제이제일제당 주식회사 L-아미노산을 생산하는 미생물 및 이를 이용하여 l-아미노산을 생산하는 방법
WO2016120387A1 (en) 2015-01-29 2016-08-04 Ares Trading S.A. Immunoassays for high positively charged proteins
EP3322736B1 (en) * 2015-07-15 2021-09-01 Prosit Sole Biotechnology (Beijing) Co., Ltd Fusion polypeptides and methods of use
PL3688468T3 (pl) 2017-09-29 2022-07-18 Merck Patent Gmbh Biomarkery stanu zapalnego do przewidywania odpowiedzi na związek fgf-18
DK3687558T3 (da) 2017-09-29 2022-06-20 Merck Patent Gmbh Metaboliske biomarkører til forudsigelse af modtageligheden på fgf-18 forbindelse
IL281333B2 (en) 2018-09-10 2025-11-01 Merck Patent Gmbh A method for reducing risk in a clinical trial
CN110759986B (zh) * 2019-10-18 2023-01-31 大连工业大学 一种可逆自组装蛋白的高效制备方法
CN114181321B (zh) * 2021-12-10 2023-04-11 中国海洋大学 花鲈fgf6a、fgf6b以及fgf18重组蛋白及其制备方法和应用
JPWO2024084807A1 (pl) * 2022-10-19 2024-04-25

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439818A (en) 1985-09-12 1995-08-08 Scios Nova Inc. DNA encoding human recombinant basic fibroblast growth factor
US5604293A (en) 1985-09-12 1997-02-18 Scios Inc. Recombinant human basic fibroblast growth factor
US5773252A (en) 1995-06-05 1998-06-30 Human Genome Sciences, Inc. Fibroblast growth factor 15
US7135459B2 (en) 1996-10-16 2006-11-14 Zymogenetics, Inc. Methods of use of FGF homologs
IL129379A (en) 1996-10-16 2008-12-29 Zymogenetics Inc Fibroblast growth factor homologues
US20050043234A1 (en) 1996-10-16 2005-02-24 Deisher Theresa A. Novel FGF homologs
US6518236B1 (en) 1996-10-16 2003-02-11 Zymogenetics, Inc. FGF homologs
JP5209161B2 (ja) 1999-12-02 2013-06-12 ザイモジェネティクス, インコーポレイテッド 腺維芽細胞成長受容体−3又は−2を発現する細胞を標的化するための方法
US20040136970A1 (en) * 2002-10-07 2004-07-15 Ellsworth Jeff L. Methods for administering FGF18
US20040229292A1 (en) 2002-11-26 2004-11-18 Sebastiano Cavallaro Use of FGF-18 in the diagnosis and treatment of memory disorders

Also Published As

Publication number Publication date
AU2005314438A1 (en) 2006-06-15
DK1828239T3 (da) 2011-12-19
CY1112394T1 (el) 2015-12-09
WO2006063362A1 (en) 2006-06-15
ES2371219T3 (es) 2011-12-28
US7858341B2 (en) 2010-12-28
EP1828239B1 (en) 2011-08-24
ATE521633T1 (de) 2011-09-15
EP1828239A1 (en) 2007-09-05
US20060172384A1 (en) 2006-08-03
CA2592261A1 (en) 2006-06-15
PT1828239E (pt) 2011-10-27
SI1828239T1 (sl) 2011-11-30
HK1113161A1 (en) 2008-09-26
CA2592261C (en) 2015-11-24
AU2005314438B2 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
IL198074A0 (en) Il-21 production in prokaryotic hosts
PT1828239E (pt) Produção de fgf18 em hospedeiros procarióticos
MY156855A (en) Novel regulatory elements
NZ600540A (en) Ethanol production in non-recombinant hosts
Jeon et al. Itaconic acid production from glycerol using Escherichia coli harboring a random synonymous codon‐substituted 5′‐coding region variant of the cadA gene
WO2009011258A1 (ja) 外来遺伝子を細胞に安定に保持する方法
BRPI0409895A (pt) métodos para cultivar células imortalizadas pelas seqüências e1 de adenovìrus e para produzir um produto em células imortalizadas pelas seqüências e1 de adenovìrus, e, cultura de células imortalizadas pelas seqüências e1 de adenovìrus
MY185040A (en) Cell culture improvements
CN104059872A (zh) 高产n-乙酰氨基葡萄糖代谢工程菌及其构建方法和应用
RU2010140417A (ru) Способы трансформации дрожжей
CN104450746A (zh) 一种向蛋白质定点引入非天然氨基酸的方法
CN103865944A (zh) 一种生产核黄素的大肠杆菌菌株及构建方法及用途
CN103409341A (zh) relA基因在提高班堡链霉菌默诺霉素产量中的应用及菌株
CN110016458A (zh) 一种发酵合成α-红没药醇的工程菌株及其构建方法
CN102776217B (zh) 一种提高l-5-甲基四氢叶酸累积量的生物合成方法
WO2005093069A3 (en) Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
KR102269939B1 (ko) 포름산 트랜스포터에서 돌연변이를 가진 써모코코스 온누리에누스 wtf-156t 및 이를 이용한 수소 생산 방법
NZ611164A (en) Compositions and methods of producing enterokinase in yeast
MX2009011385A (es) Optimizacion de produccion de colicina.
WO2021042045A8 (en) Methods for scalable gene insertions
CN121737063A (zh) 4-羟基苯丙酮酸双加氧酶突变体及其在合成β-羟基-β-甲基丁酸中的应用
WO2007046943A3 (en) Method of producing biotin
WO2009050498A3 (en) Chimeric constructs for eukaryotic membrane expression in prokaryotic cells
CN105087603A (zh) 一种生产辅酶q10的方法
MX342245B (es) Cepa de escherichia coli con mutaciones para la alta produccion de acidos nucleicos recombinantes con una baja acumulacion de acetato y su uso en cultivos de alta densidad celular en modo lote.